GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Center Laboratories Inc (ROCO:4123) » Definitions » Cyclically Adjusted PS Ratio

Center Laboratories (ROCO:4123) Cyclically Adjusted PS Ratio : 3.24 (As of Jun. 10, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Center Laboratories Cyclically Adjusted PS Ratio?

As of today (2024-06-10), Center Laboratories's current share price is NT$48.40. Center Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was NT$14.93. Center Laboratories's Cyclically Adjusted PS Ratio for today is 3.24.

The historical rank and industry rank for Center Laboratories's Cyclically Adjusted PS Ratio or its related term are showing as below:

ROCO:4123' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.89   Med: 3.36   Max: 4.97
Current: 3.24

During the past years, Center Laboratories's highest Cyclically Adjusted PS Ratio was 4.97. The lowest was 1.89. And the median was 3.36.

ROCO:4123's Cyclically Adjusted PS Ratio is ranked worse than
66.62% of 743 companies
in the Drug Manufacturers industry
Industry Median: 2.05 vs ROCO:4123: 3.24

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Center Laboratories's adjusted revenue per share data for the three months ended in Mar. 2024 was NT$0.526. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is NT$14.93 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Center Laboratories Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Center Laboratories's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Center Laboratories Cyclically Adjusted PS Ratio Chart

Center Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.23 3.90 3.55 3.02 3.02

Center Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.90 3.44 3.11 3.02 2.90

Competitive Comparison of Center Laboratories's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Center Laboratories's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Center Laboratories's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Center Laboratories's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Center Laboratories's Cyclically Adjusted PS Ratio falls into.



Center Laboratories Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Center Laboratories's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=48.40/14.93
=3.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Center Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Center Laboratories's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.526/131.7762*131.7762
=0.526

Current CPI (Mar. 2024) = 131.7762.

Center Laboratories Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.513 100.560 0.672
201409 0.543 100.428 0.712
201412 0.532 99.070 0.708
201503 0.511 99.621 0.676
201506 0.585 100.684 0.766
201509 4.267 100.392 5.601
201512 5.691 99.792 7.515
201603 6.086 100.470 7.982
201606 6.903 101.688 8.946
201609 6.267 101.861 8.108
201612 8.128 101.863 10.515
201703 6.885 102.862 8.820
201706 7.626 103.349 9.724
201709 8.925 104.136 11.294
201712 10.686 104.011 13.539
201803 9.417 105.290 11.786
201806 12.716 106.317 15.761
201809 9.719 106.507 12.025
201812 4.016 105.998 4.993
201903 0.620 107.251 0.762
201906 0.614 108.070 0.749
201909 0.585 108.329 0.712
201912 0.636 108.420 0.773
202003 0.491 108.902 0.594
202006 0.175 108.767 0.212
202009 0.206 109.815 0.247
202012 0.258 109.897 0.309
202103 0.238 111.754 0.281
202106 0.201 114.631 0.231
202109 0.138 115.734 0.157
202112 0.181 117.630 0.203
202203 0.227 121.301 0.247
202206 0.320 125.017 0.337
202209 0.265 125.227 0.279
202212 0.365 125.222 0.384
202303 0.488 127.348 0.505
202306 0.477 128.729 0.488
202309 0.519 129.860 0.527
202312 0.587 129.419 0.598
202403 0.526 131.776 0.526

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Center Laboratories  (ROCO:4123) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Center Laboratories Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Center Laboratories's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Center Laboratories (ROCO:4123) Business Description

Traded in Other Exchanges
N/A
Address
No. 3-2, Park Street, 7th floor, Nangang District, Taipei, TWN
Center Laboratories Inc is active in the healthcare sector. The company provides solutions to special medication needs of infants, young children, the elderly, patients with dysphagia and special population. In addition to the diversification of new formulations of oral solution, Center Laboratories is dedicated to new drug development of CNS and pain treatment.

Center Laboratories (ROCO:4123) Headlines

No Headlines